Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide with Surfactant for Prevention of Chronic Lung Disease in Premature Infants
IRCT20171030037093N38Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of budesonide in bronchopulmonary dysplasia (BPD), sponsored by Isfahan University of Medical Sciences. Started Apr 2020; status: completed.
02
Drugs
budesonide
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on IRCT20171030037093N38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N38.